A Key Biological Mechanism in Multiple Sclerosis Has Been Identified by Scientists

A Key Biological Mechanism in Multiple Sclerosis Has Been Identified by Scientists A key underlying process implicated in multiple sclerosis (MS) – a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord, has been defined for the first time by scientists at the Gladstone Institutes. The discovery offers new hope for the people who suffer from MS, a debilitating disease for which there is no cure. Using animal models the researchers in the laboratory of Gladstone Investigator Katerina Akassogiou,...

Read More

Important News - In Need of Doctors

We need a big favor at the moment, can you help? I hope so. Our group has finally reach 1,000+ Fans and 800+ visitors on our blog, so it's time I start our official website. In this website we will have a lot of information about Multiple Sclerosis, very detailed too. For example, we will have a page all about Myelin and another page about teriflunomide, and so on. It will contain all kinds of information and we will try to make it the main source for answers for those with multiple sclerosis or care takers. This project will take more than 2 years...

Read More

Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis

A new drug has been approved by the Australian Therapeutic Goods Administration (TGA). This new drug is known as Aubagio (teriflunomide) 14 mg. Aubagio is a once-daily, oral treatment for relapsing remitting forms of multiple sclerosis. ------------------------------------------------------------------------------------------- The drug company Genzyme launched a major campaign aimed to get their new drug to be prescribed free of charge to patients...

Read More